nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—CYP3A4—Temozolomide—melanoma	0.293	0.576	CbGbCtD
Budesonide—CYP3A4—Vemurafenib—melanoma	0.16	0.316	CbGbCtD
Budesonide—CYP3A4—Docetaxel—melanoma	0.055	0.108	CbGbCtD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—CPT1C—melanoma	0.0015	0.0759	CbGpPWpGaD
Budesonide—Sinusitis—Temozolomide—melanoma	0.00123	0.00263	CcSEcCtD
Budesonide—Haemoglobin—Carmustine—melanoma	0.00123	0.00262	CcSEcCtD
Budesonide—Haemorrhage—Carmustine—melanoma	0.00122	0.00261	CcSEcCtD
Budesonide—Flushing—Dactinomycin—melanoma	0.00121	0.00259	CcSEcCtD
Budesonide—Hypersensitivity—Vemurafenib—melanoma	0.00121	0.00258	CcSEcCtD
Budesonide—Oedema peripheral—Carmustine—melanoma	0.0012	0.00257	CcSEcCtD
Budesonide—Connective tissue disorder—Carmustine—melanoma	0.0012	0.00256	CcSEcCtD
Budesonide—Haemoglobin—Temozolomide—melanoma	0.00118	0.00253	CcSEcCtD
Budesonide—Haemorrhage—Temozolomide—melanoma	0.00118	0.00252	CcSEcCtD
Budesonide—Asthenia—Vemurafenib—melanoma	0.00117	0.00251	CcSEcCtD
Budesonide—Visual impairment—Carmustine—melanoma	0.00117	0.00251	CcSEcCtD
Budesonide—Pharyngitis—Temozolomide—melanoma	0.00117	0.0025	CcSEcCtD
Budesonide—Urinary tract disorder—Temozolomide—melanoma	0.00116	0.00249	CcSEcCtD
Budesonide—Oedema peripheral—Temozolomide—melanoma	0.00116	0.00248	CcSEcCtD
Budesonide—Pruritus—Vemurafenib—melanoma	0.00116	0.00248	CcSEcCtD
Budesonide—Connective tissue disorder—Temozolomide—melanoma	0.00116	0.00248	CcSEcCtD
Budesonide—Urethral disorder—Temozolomide—melanoma	0.00115	0.00247	CcSEcCtD
Budesonide—Alopecia—Dactinomycin—melanoma	0.00115	0.00246	CcSEcCtD
Budesonide—Eye disorder—Carmustine—melanoma	0.00114	0.00244	CcSEcCtD
Budesonide—Visual impairment—Temozolomide—melanoma	0.00114	0.00243	CcSEcCtD
Budesonide—Flushing—Carmustine—melanoma	0.00113	0.00242	CcSEcCtD
Budesonide—Ill-defined disorder—Bleomycin—melanoma	0.00113	0.00241	CcSEcCtD
Budesonide—Anaemia—Bleomycin—melanoma	0.00112	0.0024	CcSEcCtD
Budesonide—Diarrhoea—Vemurafenib—melanoma	0.00112	0.0024	CcSEcCtD
Budesonide—Migraine—Docetaxel—melanoma	0.00111	0.00238	CcSEcCtD
Budesonide—Eye disorder—Temozolomide—melanoma	0.0011	0.00236	CcSEcCtD
Budesonide—NR3C1—Regulation of Androgen receptor activity—HOXB13—melanoma	0.0011	0.0556	CbGpPWpGaD
Budesonide—Malaise—Bleomycin—melanoma	0.0011	0.00235	CcSEcCtD
Budesonide—Cardiac disorder—Temozolomide—melanoma	0.00109	0.00234	CcSEcCtD
Budesonide—Flushing—Temozolomide—melanoma	0.00109	0.00234	CcSEcCtD
Budesonide—Dizziness—Vemurafenib—melanoma	0.00108	0.00232	CcSEcCtD
Budesonide—Alopecia—Carmustine—melanoma	0.00108	0.0023	CcSEcCtD
Budesonide—Angiopathy—Temozolomide—melanoma	0.00107	0.00229	CcSEcCtD
Budesonide—Mental disorder—Carmustine—melanoma	0.00107	0.00228	CcSEcCtD
Budesonide—Immune system disorder—Temozolomide—melanoma	0.00106	0.00228	CcSEcCtD
Budesonide—Mediastinal disorder—Temozolomide—melanoma	0.00106	0.00227	CcSEcCtD
Budesonide—Malnutrition—Carmustine—melanoma	0.00106	0.00227	CcSEcCtD
Budesonide—Cough—Bleomycin—melanoma	0.00106	0.00227	CcSEcCtD
Budesonide—Ill-defined disorder—Dactinomycin—melanoma	0.00105	0.00225	CcSEcCtD
Budesonide—Anaemia—Dactinomycin—melanoma	0.00105	0.00224	CcSEcCtD
Budesonide—Vomiting—Vemurafenib—melanoma	0.00104	0.00223	CcSEcCtD
Budesonide—Alopecia—Temozolomide—melanoma	0.00104	0.00223	CcSEcCtD
Budesonide—Chest pain—Bleomycin—melanoma	0.00103	0.00221	CcSEcCtD
Budesonide—Myalgia—Bleomycin—melanoma	0.00103	0.00221	CcSEcCtD
Budesonide—Abdominal pain upper—Docetaxel—melanoma	0.00103	0.00221	CcSEcCtD
Budesonide—Rash—Vemurafenib—melanoma	0.00103	0.00221	CcSEcCtD
Budesonide—Mental disorder—Temozolomide—melanoma	0.00103	0.00221	CcSEcCtD
Budesonide—Dermatitis—Vemurafenib—melanoma	0.00103	0.00221	CcSEcCtD
Budesonide—Back pain—Carmustine—melanoma	0.00103	0.0022	CcSEcCtD
Budesonide—Headache—Vemurafenib—melanoma	0.00103	0.00219	CcSEcCtD
Budesonide—Malnutrition—Temozolomide—melanoma	0.00103	0.00219	CcSEcCtD
Budesonide—Breast disorder—Docetaxel—melanoma	0.00102	0.00219	CcSEcCtD
Budesonide—Discomfort—Bleomycin—melanoma	0.00102	0.00219	CcSEcCtD
Budesonide—Malaise—Dactinomycin—melanoma	0.00102	0.00219	CcSEcCtD
Budesonide—Cramp muscle—Docetaxel—melanoma	0.00102	0.00218	CcSEcCtD
Budesonide—Nasopharyngitis—Docetaxel—melanoma	0.00101	0.00217	CcSEcCtD
Budesonide—Dysgeusia—Temozolomide—melanoma	0.001	0.00215	CcSEcCtD
Budesonide—Confusional state—Bleomycin—melanoma	0.001	0.00214	CcSEcCtD
Budesonide—Vision blurred—Carmustine—melanoma	0.001	0.00214	CcSEcCtD
Budesonide—Tremor—Carmustine—melanoma	0.000994	0.00213	CcSEcCtD
Budesonide—Anaphylactic shock—Bleomycin—melanoma	0.000992	0.00212	CcSEcCtD
Budesonide—Back pain—Temozolomide—melanoma	0.000992	0.00212	CcSEcCtD
Budesonide—Infection—Bleomycin—melanoma	0.000986	0.00211	CcSEcCtD
Budesonide—Anaemia—Carmustine—melanoma	0.000981	0.0021	CcSEcCtD
Budesonide—Agitation—Carmustine—melanoma	0.000975	0.00209	CcSEcCtD
Budesonide—Nausea—Vemurafenib—melanoma	0.000973	0.00208	CcSEcCtD
Budesonide—Vision blurred—Temozolomide—melanoma	0.000966	0.00207	CcSEcCtD
Budesonide—Myalgia—Dactinomycin—melanoma	0.000965	0.00207	CcSEcCtD
Budesonide—Bronchospasm—Docetaxel—melanoma	0.000963	0.00206	CcSEcCtD
Budesonide—Tremor—Temozolomide—melanoma	0.000961	0.00206	CcSEcCtD
Budesonide—Discomfort—Dactinomycin—melanoma	0.000954	0.00204	CcSEcCtD
Budesonide—Ill-defined disorder—Temozolomide—melanoma	0.000951	0.00204	CcSEcCtD
Budesonide—Anaemia—Temozolomide—melanoma	0.000948	0.00203	CcSEcCtD
Budesonide—Anorexia—Bleomycin—melanoma	0.000946	0.00202	CcSEcCtD
Budesonide—Agitation—Temozolomide—melanoma	0.000942	0.00202	CcSEcCtD
Budesonide—Angioedema—Temozolomide—melanoma	0.000937	0.002	CcSEcCtD
Budesonide—Malaise—Temozolomide—melanoma	0.000925	0.00198	CcSEcCtD
Budesonide—Vertigo—Temozolomide—melanoma	0.000921	0.00197	CcSEcCtD
Budesonide—Infection—Dactinomycin—melanoma	0.000919	0.00197	CcSEcCtD
Budesonide—Hypertension—Carmustine—melanoma	0.000916	0.00196	CcSEcCtD
Budesonide—Palpitations—Temozolomide—melanoma	0.000906	0.00194	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Bleomycin—melanoma	0.000904	0.00193	CcSEcCtD
Budesonide—Chest pain—Carmustine—melanoma	0.000903	0.00193	CcSEcCtD
Budesonide—Myalgia—Carmustine—melanoma	0.000903	0.00193	CcSEcCtD
Budesonide—Anxiety—Carmustine—melanoma	0.0009	0.00193	CcSEcCtD
Budesonide—Cough—Temozolomide—melanoma	0.000895	0.00191	CcSEcCtD
Budesonide—Paraesthesia—Bleomycin—melanoma	0.000891	0.00191	CcSEcCtD
Budesonide—Weight increased—Docetaxel—melanoma	0.000891	0.00191	CcSEcCtD
Budesonide—Hypertension—Temozolomide—melanoma	0.000885	0.00189	CcSEcCtD
Budesonide—Dyspnoea—Bleomycin—melanoma	0.000884	0.00189	CcSEcCtD
Budesonide—Anorexia—Dactinomycin—melanoma	0.000882	0.00189	CcSEcCtD
Budesonide—Confusional state—Carmustine—melanoma	0.000873	0.00187	CcSEcCtD
Budesonide—Myalgia—Temozolomide—melanoma	0.000873	0.00187	CcSEcCtD
Budesonide—Arthralgia—Temozolomide—melanoma	0.000873	0.00187	CcSEcCtD
Budesonide—Infestation—Docetaxel—melanoma	0.000873	0.00187	CcSEcCtD
Budesonide—Infestation NOS—Docetaxel—melanoma	0.000873	0.00187	CcSEcCtD
Budesonide—Anxiety—Temozolomide—melanoma	0.00087	0.00186	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000867	0.00185	CcSEcCtD
Budesonide—Discomfort—Temozolomide—melanoma	0.000863	0.00185	CcSEcCtD
Budesonide—Decreased appetite—Bleomycin—melanoma	0.000862	0.00185	CcSEcCtD
Budesonide—Infection—Carmustine—melanoma	0.00086	0.00184	CcSEcCtD
Budesonide—Dry mouth—Temozolomide—melanoma	0.000854	0.00183	CcSEcCtD
Budesonide—Pain—Bleomycin—melanoma	0.000848	0.00182	CcSEcCtD
Budesonide—Conjunctivitis—Docetaxel—melanoma	0.000848	0.00181	CcSEcCtD
Budesonide—Tachycardia—Carmustine—melanoma	0.000845	0.00181	CcSEcCtD
Budesonide—Confusional state—Temozolomide—melanoma	0.000844	0.00181	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000843	0.0018	CcSEcCtD
Budesonide—Anaphylactic shock—Temozolomide—melanoma	0.000837	0.00179	CcSEcCtD
Budesonide—Infection—Temozolomide—melanoma	0.000831	0.00178	CcSEcCtD
Budesonide—Anorexia—Carmustine—melanoma	0.000825	0.00177	CcSEcCtD
Budesonide—Epistaxis—Docetaxel—melanoma	0.000823	0.00176	CcSEcCtD
Budesonide—Nervous system disorder—Temozolomide—melanoma	0.000821	0.00176	CcSEcCtD
Budesonide—Feeling abnormal—Bleomycin—melanoma	0.000818	0.00175	CcSEcCtD
Budesonide—Skin disorder—Temozolomide—melanoma	0.000813	0.00174	CcSEcCtD
Budesonide—Dexamethasone—CYP17A1—melanoma	0.00081	0.165	CrCbGaD
Budesonide—Hyperhidrosis—Temozolomide—melanoma	0.000809	0.00173	CcSEcCtD
Budesonide—Decreased appetite—Dactinomycin—melanoma	0.000804	0.00172	CcSEcCtD
Budesonide—Fatigue—Dactinomycin—melanoma	0.000798	0.00171	CcSEcCtD
Budesonide—Anorexia—Temozolomide—melanoma	0.000798	0.00171	CcSEcCtD
Budesonide—Pain—Dactinomycin—melanoma	0.000791	0.00169	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Carmustine—melanoma	0.000789	0.00169	CcSEcCtD
Budesonide—Urticaria—Bleomycin—melanoma	0.000788	0.00169	CcSEcCtD
Budesonide—Haemoglobin—Docetaxel—melanoma	0.000787	0.00168	CcSEcCtD
Budesonide—Rhinitis—Docetaxel—melanoma	0.000785	0.00168	CcSEcCtD
Budesonide—Body temperature increased—Bleomycin—melanoma	0.000784	0.00168	CcSEcCtD
Budesonide—Haemorrhage—Docetaxel—melanoma	0.000783	0.00168	CcSEcCtD
Budesonide—Insomnia—Carmustine—melanoma	0.000783	0.00168	CcSEcCtD
Budesonide—Paraesthesia—Carmustine—melanoma	0.000778	0.00166	CcSEcCtD
Budesonide—Pharyngitis—Docetaxel—melanoma	0.000777	0.00166	CcSEcCtD
Budesonide—Urinary tract disorder—Docetaxel—melanoma	0.000774	0.00166	CcSEcCtD
Budesonide—Dyspnoea—Carmustine—melanoma	0.000772	0.00165	CcSEcCtD
Budesonide—Oedema peripheral—Docetaxel—melanoma	0.000772	0.00165	CcSEcCtD
Budesonide—Somnolence—Carmustine—melanoma	0.00077	0.00165	CcSEcCtD
Budesonide—Connective tissue disorder—Docetaxel—melanoma	0.00077	0.00165	CcSEcCtD
Budesonide—Urethral disorder—Docetaxel—melanoma	0.000768	0.00164	CcSEcCtD
Budesonide—Feeling abnormal—Dactinomycin—melanoma	0.000762	0.00163	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Temozolomide—melanoma	0.000762	0.00163	CcSEcCtD
Budesonide—Insomnia—Temozolomide—melanoma	0.000757	0.00162	CcSEcCtD
Budesonide—Gastrointestinal pain—Dactinomycin—melanoma	0.000757	0.00162	CcSEcCtD
Budesonide—Visual impairment—Docetaxel—melanoma	0.000755	0.00162	CcSEcCtD
Budesonide—Decreased appetite—Carmustine—melanoma	0.000753	0.00161	CcSEcCtD
Budesonide—Paraesthesia—Temozolomide—melanoma	0.000751	0.00161	CcSEcCtD
Budesonide—Gastrointestinal disorder—Carmustine—melanoma	0.000748	0.0016	CcSEcCtD
Budesonide—Dyspnoea—Temozolomide—melanoma	0.000746	0.0016	CcSEcCtD
Budesonide—Somnolence—Temozolomide—melanoma	0.000744	0.00159	CcSEcCtD
Budesonide—Constipation—Carmustine—melanoma	0.000741	0.00158	CcSEcCtD
Budesonide—Pain—Carmustine—melanoma	0.000741	0.00158	CcSEcCtD
Budesonide—Dyspepsia—Temozolomide—melanoma	0.000737	0.00158	CcSEcCtD
Budesonide—Eye disorder—Docetaxel—melanoma	0.000732	0.00157	CcSEcCtD
Budesonide—Abdominal pain—Dactinomycin—melanoma	0.000731	0.00156	CcSEcCtD
Budesonide—Body temperature increased—Dactinomycin—melanoma	0.000731	0.00156	CcSEcCtD
Budesonide—Hypersensitivity—Bleomycin—melanoma	0.000731	0.00156	CcSEcCtD
Budesonide—Decreased appetite—Temozolomide—melanoma	0.000727	0.00156	CcSEcCtD
Budesonide—Flushing—Docetaxel—melanoma	0.000727	0.00156	CcSEcCtD
Budesonide—Cardiac disorder—Docetaxel—melanoma	0.000727	0.00156	CcSEcCtD
Budesonide—Gastrointestinal disorder—Temozolomide—melanoma	0.000723	0.00155	CcSEcCtD
Budesonide—Fatigue—Temozolomide—melanoma	0.000722	0.00154	CcSEcCtD
Budesonide—Pain—Temozolomide—melanoma	0.000716	0.00153	CcSEcCtD
Budesonide—Constipation—Temozolomide—melanoma	0.000716	0.00153	CcSEcCtD
Budesonide—Feeling abnormal—Carmustine—melanoma	0.000714	0.00153	CcSEcCtD
Budesonide—Asthenia—Bleomycin—melanoma	0.000712	0.00152	CcSEcCtD
Budesonide—Angiopathy—Docetaxel—melanoma	0.000711	0.00152	CcSEcCtD
Budesonide—Gastrointestinal pain—Carmustine—melanoma	0.000708	0.00152	CcSEcCtD
Budesonide—Immune system disorder—Docetaxel—melanoma	0.000708	0.00151	CcSEcCtD
Budesonide—Mediastinal disorder—Docetaxel—melanoma	0.000706	0.00151	CcSEcCtD
Budesonide—Pruritus—Bleomycin—melanoma	0.000702	0.0015	CcSEcCtD
Budesonide—Alopecia—Docetaxel—melanoma	0.000692	0.00148	CcSEcCtD
Budesonide—Feeling abnormal—Temozolomide—melanoma	0.00069	0.00148	CcSEcCtD
Budesonide—Mental disorder—Docetaxel—melanoma	0.000686	0.00147	CcSEcCtD
Budesonide—Abdominal pain—Carmustine—melanoma	0.000685	0.00146	CcSEcCtD
Budesonide—Body temperature increased—Carmustine—melanoma	0.000685	0.00146	CcSEcCtD
Budesonide—Gastrointestinal pain—Temozolomide—melanoma	0.000684	0.00146	CcSEcCtD
Budesonide—Malnutrition—Docetaxel—melanoma	0.000682	0.00146	CcSEcCtD
Budesonide—Hypersensitivity—Dactinomycin—melanoma	0.000682	0.00146	CcSEcCtD
Budesonide—Dysgeusia—Docetaxel—melanoma	0.000668	0.00143	CcSEcCtD
Budesonide—Urticaria—Temozolomide—melanoma	0.000665	0.00142	CcSEcCtD
Budesonide—Asthenia—Dactinomycin—melanoma	0.000664	0.00142	CcSEcCtD
Budesonide—Body temperature increased—Temozolomide—melanoma	0.000662	0.00142	CcSEcCtD
Budesonide—Abdominal pain—Temozolomide—melanoma	0.000662	0.00142	CcSEcCtD
Budesonide—Dexamethasone—NOS2—melanoma	0.000661	0.134	CrCbGaD
Budesonide—Back pain—Docetaxel—melanoma	0.00066	0.00141	CcSEcCtD
Budesonide—Muscle spasms—Docetaxel—melanoma	0.000656	0.0014	CcSEcCtD
Budesonide—Hypersensitivity—Carmustine—melanoma	0.000638	0.00137	CcSEcCtD
Budesonide—Diarrhoea—Dactinomycin—melanoma	0.000633	0.00135	CcSEcCtD
Budesonide—Vomiting—Bleomycin—melanoma	0.000631	0.00135	CcSEcCtD
Budesonide—Anaemia—Docetaxel—melanoma	0.00063	0.00135	CcSEcCtD
Budesonide—Rash—Bleomycin—melanoma	0.000626	0.00134	CcSEcCtD
Budesonide—Dermatitis—Bleomycin—melanoma	0.000625	0.00134	CcSEcCtD
Budesonide—Asthenia—Carmustine—melanoma	0.000621	0.00133	CcSEcCtD
Budesonide—Hypersensitivity—Temozolomide—melanoma	0.000617	0.00132	CcSEcCtD
Budesonide—Syncope—Docetaxel—melanoma	0.000612	0.00131	CcSEcCtD
Budesonide—Palpitations—Docetaxel—melanoma	0.000603	0.00129	CcSEcCtD
Budesonide—Asthenia—Temozolomide—melanoma	0.0006	0.00128	CcSEcCtD
Budesonide—Loss of consciousness—Docetaxel—melanoma	0.000599	0.00128	CcSEcCtD
Budesonide—Cough—Docetaxel—melanoma	0.000595	0.00127	CcSEcCtD
Budesonide—Diarrhoea—Carmustine—melanoma	0.000593	0.00127	CcSEcCtD
Budesonide—Pruritus—Temozolomide—melanoma	0.000592	0.00127	CcSEcCtD
Budesonide—Nausea—Bleomycin—melanoma	0.000589	0.00126	CcSEcCtD
Budesonide—Hypertension—Docetaxel—melanoma	0.000589	0.00126	CcSEcCtD
Budesonide—Vomiting—Dactinomycin—melanoma	0.000588	0.00126	CcSEcCtD
Budesonide—Rash—Dactinomycin—melanoma	0.000583	0.00125	CcSEcCtD
Budesonide—Chest pain—Docetaxel—melanoma	0.000581	0.00124	CcSEcCtD
Budesonide—Myalgia—Docetaxel—melanoma	0.000581	0.00124	CcSEcCtD
Budesonide—Arthralgia—Docetaxel—melanoma	0.000581	0.00124	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000577	0.00123	CcSEcCtD
Budesonide—Dizziness—Carmustine—melanoma	0.000573	0.00123	CcSEcCtD
Budesonide—Diarrhoea—Temozolomide—melanoma	0.000573	0.00123	CcSEcCtD
Budesonide—Dry mouth—Docetaxel—melanoma	0.000568	0.00121	CcSEcCtD
Budesonide—Dexamethasone—CYP1B1—melanoma	0.000562	0.114	CrCbGaD
Budesonide—Confusional state—Docetaxel—melanoma	0.000561	0.0012	CcSEcCtD
Budesonide—Anaphylactic shock—Docetaxel—melanoma	0.000557	0.00119	CcSEcCtD
Budesonide—Dizziness—Temozolomide—melanoma	0.000553	0.00118	CcSEcCtD
Budesonide—Infection—Docetaxel—melanoma	0.000553	0.00118	CcSEcCtD
Budesonide—Vomiting—Carmustine—melanoma	0.000551	0.00118	CcSEcCtD
Budesonide—Nausea—Dactinomycin—melanoma	0.00055	0.00118	CcSEcCtD
Budesonide—Shock—Docetaxel—melanoma	0.000548	0.00117	CcSEcCtD
Budesonide—Rash—Carmustine—melanoma	0.000546	0.00117	CcSEcCtD
Budesonide—Nervous system disorder—Docetaxel—melanoma	0.000546	0.00117	CcSEcCtD
Budesonide—Dermatitis—Carmustine—melanoma	0.000546	0.00117	CcSEcCtD
Budesonide—Tachycardia—Docetaxel—melanoma	0.000543	0.00116	CcSEcCtD
Budesonide—Headache—Carmustine—melanoma	0.000543	0.00116	CcSEcCtD
Budesonide—Skin disorder—Docetaxel—melanoma	0.000541	0.00116	CcSEcCtD
Budesonide—Vomiting—Temozolomide—melanoma	0.000532	0.00114	CcSEcCtD
Budesonide—Anorexia—Docetaxel—melanoma	0.00053	0.00114	CcSEcCtD
Budesonide—Rash—Temozolomide—melanoma	0.000528	0.00113	CcSEcCtD
Budesonide—Dermatitis—Temozolomide—melanoma	0.000527	0.00113	CcSEcCtD
Budesonide—Headache—Temozolomide—melanoma	0.000524	0.00112	CcSEcCtD
Budesonide—Nausea—Carmustine—melanoma	0.000514	0.0011	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Docetaxel—melanoma	0.000507	0.00108	CcSEcCtD
Budesonide—Insomnia—Docetaxel—melanoma	0.000503	0.00108	CcSEcCtD
Budesonide—Paraesthesia—Docetaxel—melanoma	0.0005	0.00107	CcSEcCtD
Budesonide—NR3C1—Signaling events mediated by HDAC Class II—HDAC6—melanoma	0.000498	0.0252	CbGpPWpGaD
Budesonide—Nausea—Temozolomide—melanoma	0.000497	0.00106	CcSEcCtD
Budesonide—Dyspnoea—Docetaxel—melanoma	0.000496	0.00106	CcSEcCtD
Budesonide—Somnolence—Docetaxel—melanoma	0.000495	0.00106	CcSEcCtD
Budesonide—Dyspepsia—Docetaxel—melanoma	0.00049	0.00105	CcSEcCtD
Budesonide—Decreased appetite—Docetaxel—melanoma	0.000484	0.00104	CcSEcCtD
Budesonide—Gastrointestinal disorder—Docetaxel—melanoma	0.00048	0.00103	CcSEcCtD
Budesonide—Fatigue—Docetaxel—melanoma	0.00048	0.00103	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—ASIP—melanoma	0.000477	0.0242	CbGpPWpGaD
Budesonide—Pain—Docetaxel—melanoma	0.000476	0.00102	CcSEcCtD
Budesonide—Constipation—Docetaxel—melanoma	0.000476	0.00102	CcSEcCtD
Budesonide—Feeling abnormal—Docetaxel—melanoma	0.000459	0.000981	CcSEcCtD
Budesonide—Gastrointestinal pain—Docetaxel—melanoma	0.000455	0.000974	CcSEcCtD
Budesonide—Abdominal pain—Docetaxel—melanoma	0.00044	0.000941	CcSEcCtD
Budesonide—Body temperature increased—Docetaxel—melanoma	0.00044	0.000941	CcSEcCtD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K2—melanoma	0.000422	0.0214	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—POU3F2—melanoma	0.000412	0.0209	CbGpPWpGaD
Budesonide—Hypersensitivity—Docetaxel—melanoma	0.00041	0.000877	CcSEcCtD
Budesonide—Methylprednisolone—ABCB1—melanoma	0.000401	0.0817	CrCbGaD
Budesonide—Asthenia—Docetaxel—melanoma	0.000399	0.000854	CcSEcCtD
Budesonide—Triamcinolone—PTGS2—melanoma	0.000398	0.081	CrCbGaD
Budesonide—Pruritus—Docetaxel—melanoma	0.000394	0.000842	CcSEcCtD
Budesonide—NR3C1—Endoderm Differentiation—NODAL—melanoma	0.000391	0.0198	CbGpPWpGaD
Budesonide—Diarrhoea—Docetaxel—melanoma	0.000381	0.000815	CcSEcCtD
Budesonide—Dizziness—Docetaxel—melanoma	0.000368	0.000787	CcSEcCtD
Budesonide—Vomiting—Docetaxel—melanoma	0.000354	0.000757	CcSEcCtD
Budesonide—Rash—Docetaxel—melanoma	0.000351	0.000751	CcSEcCtD
Budesonide—Dermatitis—Docetaxel—melanoma	0.000351	0.00075	CcSEcCtD
Budesonide—Headache—Docetaxel—melanoma	0.000349	0.000746	CcSEcCtD
Budesonide—CYP3A4—Liver X Receptor Pathway—FASN—melanoma	0.000346	0.0175	CbGpPWpGaD
Budesonide—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—melanoma	0.000343	0.0174	CbGpPWpGaD
Budesonide—Nausea—Docetaxel—melanoma	0.000331	0.000707	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SKI—melanoma	0.000329	0.0167	CbGpPWpGaD
Budesonide—Betamethasone—PTGS2—melanoma	0.000326	0.0663	CrCbGaD
Budesonide—Prednisone—ALB—melanoma	0.000322	0.0654	CrCbGaD
Budesonide—NR3C1—AP-1 transcription factor network—BCL2L11—melanoma	0.000318	0.0161	CbGpPWpGaD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—melanoma	0.000318	0.0161	CbGpPWpGaD
Budesonide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—melanoma	0.00031	0.0157	CbGpPWpGaD
Budesonide—Prednisone—ABCB1—melanoma	0.000307	0.0625	CrCbGaD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—melanoma	0.000299	0.0152	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—melanoma	0.00029	0.0147	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—NPPA—melanoma	0.000289	0.0147	CbGpPWpGaD
Budesonide—Prednisolone—ABCB1—melanoma	0.000283	0.0576	CrCbGaD
Budesonide—Betamethasone—ABCB1—melanoma	0.000277	0.0564	CrCbGaD
Budesonide—NR3C1—Nuclear Receptors—VDR—melanoma	0.000269	0.0136	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—ETS1—melanoma	0.000258	0.0131	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—MAP2—melanoma	0.000237	0.012	CbGpPWpGaD
Budesonide—Hydrocortisone—ABCB1—melanoma	0.000216	0.044	CrCbGaD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—VDR—melanoma	0.000212	0.0108	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—TP73—melanoma	0.000201	0.0102	CbGpPWpGaD
Budesonide—CYP3A4—Estrogen metabolism—CYP1B1—melanoma	0.000197	0.00998	CbGpPWpGaD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—melanoma	0.000191	0.0097	CbGpPWpGaD
Budesonide—Dexamethasone—PTGS2—melanoma	0.00019	0.0386	CrCbGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO4—melanoma	0.000188	0.00955	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—melanoma	0.000188	0.00955	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptors—PPARG—melanoma	0.000187	0.0095	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—melanoma	0.000187	0.00946	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—melanoma	0.000185	0.00937	CbGpPWpGaD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—melanoma	0.000182	0.00923	CbGpPWpGaD
Budesonide—CYP3A4—Tamoxifen metabolism—CYP1B1—melanoma	0.000174	0.00882	CbGpPWpGaD
Budesonide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—melanoma	0.00017	0.0086	CbGpPWpGaD
Budesonide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—melanoma	0.000169	0.00858	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—HIF1A—melanoma	0.000164	0.00831	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—EDN1—melanoma	0.000162	0.00823	CbGpPWpGaD
Budesonide—Dexamethasone—ABCB1—melanoma	0.000161	0.0328	CrCbGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL10—melanoma	0.00016	0.00813	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CSF2—melanoma	0.000159	0.00804	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL4—melanoma	0.000156	0.00791	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—melanoma	0.000154	0.00781	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—melanoma	0.00015	0.00763	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—melanoma	0.00015	0.0076	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—melanoma	0.000148	0.00751	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—melanoma	0.000147	0.00744	CbGpPWpGaD
Budesonide—CYP3A4—Irinotecan Pathway—APC—melanoma	0.000143	0.00724	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—melanoma	0.000143	0.00724	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—HLA-A—melanoma	0.000141	0.00717	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—CSF2—melanoma	0.00014	0.00709	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL4—melanoma	0.000137	0.00697	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—MMP1—melanoma	0.000136	0.00691	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—HIF1A—melanoma	0.000135	0.00685	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—NOTCH1—melanoma	0.000125	0.00632	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—melanoma	0.000124	0.00631	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—APC—melanoma	0.000122	0.00618	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—melanoma	0.00012	0.00609	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—melanoma	0.000119	0.00604	CbGpPWpGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—MDM2—melanoma	0.000117	0.00594	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—UGT2B10—melanoma	0.000115	0.00585	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—melanoma	0.000113	0.00571	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—melanoma	0.000109	0.00554	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—SOCS1—melanoma	0.000109	0.00553	CbGpPWpGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	0.000102	0.00519	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	9.75e-05	0.00494	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	9.73e-05	0.00493	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CDKN2A—melanoma	9.67e-05	0.0049	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—E2F1—melanoma	9.46e-05	0.0048	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IFNG—melanoma	9.43e-05	0.00478	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—CLNS1A—melanoma	9.4e-05	0.00477	CbGpPWpGaD
Budesonide—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	9.29e-05	0.00471	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	8.93e-05	0.00453	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	8.81e-05	0.00447	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CXCL8—melanoma	8.77e-05	0.00445	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—FAS—melanoma	8.76e-05	0.00444	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CDKN1B—melanoma	8.57e-05	0.00434	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL10—melanoma	8.45e-05	0.00428	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL2—melanoma	8.38e-05	0.00425	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—melanoma	8.31e-05	0.00421	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—CTNNB1—melanoma	8.28e-05	0.0042	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—melanoma	8.27e-05	0.00419	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—HIF1A—melanoma	8.24e-05	0.00418	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—SKI—melanoma	8.23e-05	0.00417	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CCND1—melanoma	8.17e-05	0.00414	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CTNNB1—melanoma	8.09e-05	0.0041	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—MMP9—melanoma	7.93e-05	0.00402	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—PTEN—melanoma	7.89e-05	0.004	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—melanoma	7.73e-05	0.00392	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	7.51e-05	0.00381	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	7.41e-05	0.00376	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—melanoma	7.39e-05	0.00374	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	7.33e-05	0.00372	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	7.24e-05	0.00367	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—melanoma	7.12e-05	0.00361	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—melanoma	7.03e-05	0.00357	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—PPARG—melanoma	7.01e-05	0.00355	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—melanoma	6.96e-05	0.00353	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—melanoma	6.92e-05	0.00351	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	6.78e-05	0.00344	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—RB1—melanoma	6.71e-05	0.0034	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IGF1—melanoma	6.65e-05	0.00337	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—melanoma	6.59e-05	0.00334	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—MYC—melanoma	6.55e-05	0.00332	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—NPPA—melanoma	6.44e-05	0.00327	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	6.09e-05	0.00309	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—melanoma	5.94e-05	0.00301	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—melanoma	5.83e-05	0.00296	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—melanoma	5.65e-05	0.00286	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—TP53—melanoma	5.38e-05	0.00273	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—CTNNB1—melanoma	4.93e-05	0.0025	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL6—melanoma	4.93e-05	0.0025	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—CDKN1A—melanoma	4.82e-05	0.00244	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—melanoma	4.74e-05	0.0024	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—melanoma	4.62e-05	0.00234	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CASP3—melanoma	4.42e-05	0.00224	CbGpPWpGaD
Budesonide—CYP3A4—Tryptophan metabolism—MDM2—melanoma	4.34e-05	0.0022	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—melanoma	4.34e-05	0.0022	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—STAT3—melanoma	4.3e-05	0.00218	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—melanoma	4.26e-05	0.00216	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—NFKB1—melanoma	4.13e-05	0.0021	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	4.04e-05	0.00205	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—RPS3—melanoma	4.03e-05	0.00204	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—melanoma	4e-05	0.00203	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SKI—melanoma	3.96e-05	0.00201	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SNRPE—melanoma	3.96e-05	0.00201	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP17A1—melanoma	3.84e-05	0.00195	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	3.79e-05	0.00192	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—CDKN2B—melanoma	3.76e-05	0.00191	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—melanoma	3.75e-05	0.0019	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—TNF—melanoma	3.72e-05	0.00189	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—VDR—melanoma	3.67e-05	0.00186	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP1B1—melanoma	3.24e-05	0.00164	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—TNF—melanoma	3.22e-05	0.00163	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	3.19e-05	0.00162	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—NPPA—melanoma	3.1e-05	0.00157	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IL6—melanoma	3e-05	0.00152	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—NOTCH1—melanoma	2.71e-05	0.00137	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL6—melanoma	2.6e-05	0.00132	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—PPARG—melanoma	2.56e-05	0.0013	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—HDAC2—melanoma	2.27e-05	0.00115	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ACER3—melanoma	2.16e-05	0.00109	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—UGT2B10—melanoma	1.97e-05	0.001	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HS3ST5—melanoma	1.83e-05	0.00093	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—CDKN2B—melanoma	1.81e-05	0.000919	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—VDR—melanoma	1.77e-05	0.000896	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PRKCA—melanoma	1.63e-05	0.000826	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ERCC2—melanoma	1.62e-05	0.000819	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—MYC—melanoma	1.46e-05	0.000739	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PLCB4—melanoma	1.39e-05	0.000705	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIP4K2A—melanoma	1.31e-05	0.000662	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC6A11—melanoma	1.31e-05	0.000662	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—NOTCH1—melanoma	1.31e-05	0.000662	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MTAP—melanoma	1.27e-05	0.000644	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PPARG—melanoma	1.23e-05	0.000624	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PHGDH—melanoma	1.13e-05	0.000574	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LUM—melanoma	1.13e-05	0.000574	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HPSE—melanoma	1.11e-05	0.000563	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CUBN—melanoma	1.09e-05	0.000553	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SDHD—melanoma	1.05e-05	0.000534	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—BSG—melanoma	1.05e-05	0.000534	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CSPG4—melanoma	1.05e-05	0.000534	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GPAM—melanoma	1.02e-05	0.000517	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PLA2G6—melanoma	8.67e-06	0.00044	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—VCAN—melanoma	7.79e-06	0.000395	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—MAPK3—melanoma	7.22e-06	0.000366	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—MYC—melanoma	7.02e-06	0.000356	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP17A1—melanoma	6.57e-06	0.000333	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GNA11—melanoma	6.21e-06	0.000315	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—FASN—melanoma	6.07e-06	0.000308	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC5A5—melanoma	5.98e-06	0.000303	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GNAQ—melanoma	5.77e-06	0.000293	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CD44—melanoma	5.77e-06	0.000293	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP1B1—melanoma	5.53e-06	0.000281	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—AKT1—melanoma	4.87e-06	0.000247	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ABCB1—melanoma	4.56e-06	0.000231	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PRKCA—melanoma	4.19e-06	0.000213	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ERCC2—melanoma	4.16e-06	0.000211	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CG—melanoma	3.28e-06	0.000167	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPARG—melanoma	3.17e-06	0.000161	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CD—melanoma	2.89e-06	0.000146	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALB—melanoma	2.85e-06	0.000145	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CB—melanoma	2.52e-06	0.000128	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PTGS2—melanoma	2.49e-06	0.000126	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PTEN—melanoma	2.17e-06	0.00011	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CA—melanoma	1.53e-06	7.78e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AKT1—melanoma	1.25e-06	6.35e-05	CbGpPWpGaD
